2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy

Cites (468)

Items 201–400 of 468

1. Adverse Prognosis of Patients With Hypertrophic Cardiomyopathy Who Have Epicardial Coronary Artery Disease
   Paul Sorajja, Steve R. Ommen, Rick A. Nishimura, Bernard John Gersh, Peter B. Berger, Abdul Jamil Tajik · 2003 · Circulation
2. Noonan syndrome and related disorders: dysregulated RAS-mitogen activated protein kinase signal transduction
   Bruce D. Gelb, Marco Tartaglia · 2006 · Human Molecular Genetics
3. Long-term Clinical and Echocardiographic Follow-up After Surgical Correction of Hypertrophic Obstructive Cardiomyopathy With Extended Myectomy and Reconstruction of the Subvalvular Mitral Apparatus
   Friedrich A. Schöndube, Heinrich G. Klues, Sebastian Reith, Frank Arnold Flachskampf, Peter Hanrath, Bruno J. Messmer · 1995 · Circulation
4. Clinical course of hypertrophiccardiomyopathy with survival to advanced age
   Barry J. Maron, Susan A. Casey, Robert G. Hauser, Dorothee M. Aeppli · 2003 · Journal of the American College of Cardiology
5. The Prevalence and Anatomical Patterns of Intramuscular Coronary Arteries
   Eli Konen, Orly Goitein, Leonid Sternik · 2007 · Journal of the American College of Cardiology
6. Comprehensive Analysis of the Beta-Myosin Heavy Chain Gene in 389 Unrelated Patients With Hypertrophic Cardiomyopathy
   Sara L. Van Driest, Michele A. Jaeger, Steve R. Ommen, Melissa L. Will, Bernard John Gersh, Abdul Jamil Tajik, Michael John Ackerman · 2004 · Journal of the American College of Cardiology
7. ACCF/ASE/ACEP/AHA/ASNC/SCAI/SCCT/SCMR 2008 Appropriateness Criteria for Stress Echocardiography⁎⁎Developed in accordance with the principles and methodology outlined by ACCF: Patel MR, Spertus JA, Brindis RG, Hendel RC, Douglas PS, Peterson ED, Wolk MJ, Allen JM, Raskin IE. ACCF proposed method for evaluating the appropriateness of cardiovascular imaging. J Am Coll Cardiol 2005;46:1606–13.
   Pamela S. Douglas, Bijoy K. Khandheria, Raymond F. Stainback · 2008 · Journal of the American College of Cardiology
8. Doppler echocardiographic determination of the pressure gradient in hypertrophic cardiomyopathy
   Zion Sasson, Paul G. Yock, Liv K. Hatle, Edwin L. Alderman, Richard L. Popp · 1988 · Journal of the American College of Cardiology
9. Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy
   Barry J. Maron, Jonathan G. Seidman, Christine E. Seidman · 2004 · Journal of the American College of Cardiology
10. Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy
    Deborah H. Kwon, Randolph M. Setser, Maran Thamilarasan · 2007 · Heart
11. Preclinical diagnosis of familial hypertrophic cardiomyopathy by genetic analysis of blood lymphocytes
    Rosenzweig, Anthony, Watkins, Hugh, Hwang, Dar-San, Miri, Mohammad, McKenna, William, Traill, Thomas A., Seidman, J.G., Seidman, Christine E. · 1991 · New England Journal of Medicine
12. Hypertrophic cardiomyopathy in the elderly. Distinctions from the young based on cardiac shape.
    Harry M. Lever, Roger Karam, Philip J. Currie · 1989 · Circulation
13. Surgical Relief of Diffuse Subvalvular Aortic Stenosis
    John W. Kirklin, F. Henry Ellis · 1961 · Circulation
14. Danon Disease as an Underrecognized Cause of Hypertrophic Cardiomyopathy in Children
    Yang Yu Zhao, Colin Joseph McMahon, Liana R. Smith, Jeathrina Bersola, Adekunle M. Adesina, John P. Breinholt, Debra Lynn Kearney, William J. Dreyer, Susan W. Denfield, Jack F. Price et al. · 2005 · Circulation
15. An echocardiographic study of the fluid machanics of obstruction in hypertrophic cardiomyopathy
    Mark V. Sherrid, C.K. Chu, Ernest Delia, Allen Mograder, Edward M. Dwyer · 1993 · Journal of the American College of Cardiology
16. Prevalence and Severity of “Benign” Mutations in the β-Myosin Heavy Chain, Cardiac Troponin T, and α-Tropomyosin Genes in Hypertrophic Cardiomyopathy
    Sara L. Van Driest, Michael John Ackerman, Steve R. Ommen, Rameen Shakur, Melissa L. Will, Rick A. Nishimura, Abdul Jamil Tajik, Bernard John Gersh · 2002 · Circulation
17. Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction
    Mark V. Sherrid, Farooq A. Chaudhry, Daniel G. Swistel · 2003 · The Annals of Thoracic Surgery
18. Septal myotomy–myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes
    Sam Firoozi · 2002 · European Heart Journal
19. Hypertrophic cardiomyopathy: an important global disease
    Barry J. Maron · 2003 · The American Journal of Medicine
20. Effect of dual-chamber pacing on systolic and diastolic function in patients with hypertrophic cardiomyopathy Acute doppler echocardiographic and catheterization hemodynamic study
    Rick A. Nishimura, David L. Hayes, Duane M. Ilstrup, David R. Holmes, Abdul Jamil Tajik · 1996 · Journal of the American College of Cardiology
21. Verapamil therapy: A new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration
    Douglas R. Rosing, John R. Condit, Barry J. Maron, Kenneth M. Kent, Martin B. Leon, Robert O. Bonow, Lewis C. Lipson, Stephen E. Epstein · 1981 · The American Journal of Cardiology
22. Placebo effect of pacemaker implantation in obstructive hypertrophic cardiomyopathy
    Cecilia Marianne Linde, Fredrik Gadler, Lukas Kappenberger, Lars Rydén · 1999 · The American Journal of Cardiology
23. Multiple Mutations in Genetic Cardiovascular Disease
    Matthew Kelly, Christopher Semsarian · 2009 · Circulation Cardiovascular Genetics
24. Editorial
    Barry J. Maron, P Spirito · 1998 · The American Journal of Cardiology
25. Current operative treatment of obstructive hypertrophic cardiomyopathy.
    Charles L. McIntosh, Barry J. Maron · 1988 · Circulation
26. Surgical Myectomy Remains the Primary Treatment Option for Severely Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy
    Barry J. Maron · 2007 · Circulation
27. Echocardiographic Strain Imaging to Assess Early and Late Consequences of Sarcomere Mutations in Hypertrophic Cardiomyopathy
    Carolyn Yung Ho, Christian Malchau Carlsen, Jens Jakob Thune, Ole Havndrup, Henning Bundgaard, Faranak Farrohi, Jose Rivero, Allison L. Cirino, Paal Skytt Andersen, Michael Christiansen et al. · 2009 · Circulation Cardiovascular Genetics
28. Mechanism of Benefit of Negative Inotropes in Obstructive Hypertrophic Cardiomyopathy
    Mark V. Sherrid, Gretchen Pearle, David Z. Gunsburg · 1998 · Circulation
29. Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy.
    James E. Udelson, Robert O. Bonow, Patrick T. O’Gara · 1989 · Circulation
30. Clinical Approach to Genetic Cardiomyopathy in Children
    Marcy L. Schwartz, Gerald F. Cox, Angela E. Lin, Mark S. Korson, Antonio R. Pérez‐Atayde, Ronald V. Lacro, Steven E. Lipshultz · 1996 · Circulation
31. Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death
    Cristina Basso, Gaetano Thiene, Shannon Mackey‐Bojack, A.C. Frigo, Domenico Corrado, Barry J. Maron · 2009 · European Heart Journal
32. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients
    Lothar Faber, A Meissner, P Ziemssen, H Seggewiss · 2000 · Heart
33. Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy.
    Richard O. Cannon, Vasken Dilsizian, P T O'Gara · 1991 · Circulation
34. Significance of Papillary Muscle Abnormalities Identified by Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy
    Caitlin J. Harrigan, Evan A. Appelbaum, Barry J. Maron, Jacqueline L. Buros, Charles Michael Gibson, John R. Lesser, James E. Udelson, Warren J. Manning, Martin S. Maron · 2007 · The American Journal of Cardiology
35. Regression of Left Ventricular Hypertrophy After Nonsurgical Septal Reduction Therapy for Hypertrophic Obstructive Cardiomyopathy
    Wojciech M. Mazur, Sherif F. Nagueh, Nasser M. Lakkis, Katherine J. Middleton, Donna Killip, Robert Roberts, William H. Spencer · 2001 · Circulation
36. Enlarged Left Atrial Volume in Hypertrophic Cardiomyopathy: A Marker for Disease Severity
    Hua Yang, Anna Woo, Daniel Monakier · 2005 · Journal of the American Society of Echocardiography
37. Prevention of inappropriate therapy in implantable cardioverter-defibrillators
    Dominic A.M.J. Theuns, Anouk Klootwijk, Dick M. Goedhart, Luc J.L.M. Jordaens · 2004 · Journal of the American College of Cardiology
38. Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy
    Iacopo Olivotto, Roberto Gistri, Pasquale Petrone, Elena Pedemonte, Daniela Vargiu, Franco Cecchi · 2003 · Journal of the American College of Cardiology
39. Prevention of Cardiac Hypertrophy by Atorvastatin in a Transgenic Rabbit Model of Human Hypertrophic Cardiomyopathy
    Vinitha Senthil, Suet Nee Chen, Natalie Tsybouleva, Tripti Halder, Sherif F. Nagueh, James T. Willerson, Robert Roberts, Ali J. Marian · 2005 · Circulation Research
40. Long-Term Clinical Consequences of Intense, Uninterrupted Endurance Training in Olympic Athletes
    Pelliccia, Antonio, Kinoshita, Norimitsu, Pisicchio, Cataldo, Quattrini, Filippo, DiPaolo, Fernando M., Ciardo, Roberto, Di Giacinto, Barbara, Guerra, Emanuele, De Blasiis, Elvira, Casasco, Maurizio et al. · 2010 · Journal of the American College of Cardiology
41. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy
    Grace Lin, Rick A. Nishimura, Bernard John Gersh, D Phil, Steve R. Ommen, Michael John Ackerman, Peter A. Brady · 2009 · Heart
42. Early Onset and Progression of Left Ventricular Remodeling After Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy
    Willem G. van Dockum, Aernout M. Beek, Folkert J. ten Cate · 2005 · Circulation
43. Meta-Analyses of Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy
    Robert A. Leonardi, Evan Paul Kransdorf, David L. Simel · 2010 · Circulation Cardiovascular Interventions
44. AHA/ACCF 2009 Performance Measures for Primary Prevention of Cardiovascular Disease in Adults
    Rita F. Redberg, Emelia J. Benjamin, Vera Bittner, Lynne T. Braun, David Calvin Goff, Stephen Havas, Darwin R. Labarthe, Marian C. Limacher, Donald M. Lloyd‐Jones, Samia Mora et al. · 2009 · Circulation
45. Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience
    L FABER · 2004 · European Journal of Echocardiography
46. Alcohol septal ablation versus surgical septal myectomy
    Deepak Talreja, Rick A. Nishimura, William D. Edwards · 2004 · Journal of the American College of Cardiology
47. Homozygous Mutation in Cardiac Troponin T
    Carolyn Yung Ho, Harry M. Lever, Roman W. DeSanctis, Carol F. Farver, Jonathan G. Seidman, Christine E. Seidman · 2000 · Circulation
48. ACCF/ASE/ACEP/AHA/ASNC/SCAI/SCCT/SCMR 2008 Appropriateness Criteria for Stress Echocardiography
    STRESS ECHOCARDIOGRAPHY WRITING GROUP, Pamela S. Douglas, Bijoy K. Khandheria et al. · 2008 · Circulation
49. Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow-up
    Nasser M. Lakkis, Sherif F. Nagueh, J. Kay Dunn · 2000 · Journal of the American College of Cardiology
50. Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis
    Mahboob Alam, Hisham Dokainish, Nasser M. Lakkis · 2009 · European Heart Journal
51. Prevalence and Clinical Significance of Aortic Root Dilation in Highly Trained Competitive Athletes
    Antonio Pelliccia, Fernando Maria Di Paolo, Elvira De Blasiis, Filippo Maria Quattrini, Cataldo Pisicchio, Emanuele Guerra, Franco Culasso, Barry J. Maron · 2010 · Circulation
52. Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging
    Willem G. van Dockum, Folkert J. ten Cate, Jurriën M. ten Berg · 2004 · Journal of the American College of Cardiology
53. Hypertrophic obstructive cardiomyopathy: Comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score
    Anthony C. Ralph-Edwards, Anna Woo, Brian W. McCrindle · 2004 · Journal of Thoracic and Cardiovascular Surgery
54. Management of Symptoms in Hypertrophic Cardiomyopathy
    Michael A. Fifer, Gus J. Vlahakes · 2008 · Circulation
55. Distinguishing hypertrophic cardiomyopathy from athlete’s heart physiological remodelling: clinical significance, diagnostic strategies and implications for preparticipation screening
    Barry J. Maron · 2009 · British Journal of Sports Medicine
56. Abnormal mitral valve coaptation in hypertrophic obstructive cardiomyopathy: Proposed role in systolic anterior motion of mitral valve
    Pravin M. Shah, Richard D. Taylor, Maylene Wong · 1981 · The American Journal of Cardiology
57. Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy
    Su Min Chang, Sherif F. Nagueh, William H. Spencer · 2003 · Journal of the American College of Cardiology
58. Clinical profile of hypertrophic cardiomyopathy identified de novo in rural communities11Each of the authors contributed significantly to the submitted work including: 1) conception and design of the project and/or interpretation of data; 2) drafting and/or revising the manuscript, and 3) final approval of the submitted manuscript.
    Barry J. Maron, Robert Mathenge, Susan A. Casey, Liviu C. Poliac, Terrence F. Longe · 1999 · Journal of the American College of Cardiology
59. Muscular Subaortic Stenosis
    M.D. Flamm, Donald C. Harrison, E. William Hancock · 1968 · Circulation
60. Myocardial bridging in adult patients with hypertrophic cardiomyopathy
    Paul Sorajja, Steve R. Ommen, Rick A. Nishimura · 2003 · Journal of the American College of Cardiology
61. Functional assessment of patients treated with permanent dual chamber pacing as a primary treatment for hypertrophic cardiomyopathy
    Kenneth McDonald, Eric T. McWilliams, B O’Keeffe, BRIAN J. MAURER · 1988 · European Heart Journal
62. Factors Associated With Establishing a Causal Diagnosis for Children With Cardiomyopathy
    Gerald F. Cox, Lynn A. Sleeper, April M. Lowe · 2006 · PEDIATRICS
63. Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression
    Di Donna, P., Olivotto, I., Delcre, S. D. L., Caponi, D., Scaglione, M., Nault, I., Montefusco, A., Girolami, F., Cecchi, F., Haissaguerre, M. et al. · 2010 · Europace
64. Long-term medical management of hypertrophic obstructive cardiomyopathy
    MARTIN JEFFREY FRANK, Abdulla M. Abdulla, Mario I. Canedo · 1978 · The American Journal of Cardiology
65. Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy
    Maria Angela Losi, Sandro Betocchi, Mariano Aversa, Raffaella Lombardi, Marianna Miranda, Gianluigi D’Alessandro, Alessandra Cacace, Carlo Gabriele Tocchetti, Giovanni Barbati, Massimo Chiariello A · 2004 · The American Journal of Cardiology
66. Sporadic hypertrophic cardiomyopathy due to de novo myosin mutations.
    Hugh C Watkins, Ludwig Thierfelder, D S Hwang, William John McKenna, Jonathan G. Seidman, Christine E. Seidman · 1992 · Journal of Clinical Investigation
67. Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest
    Franco Cecchi, Barry J. Maron, Stephen E. Epstein · 1989 · Journal of the American College of Cardiology
68. Amiodarone for long-term management of patients with hypertrophic cardiomyopathy
    William John McKenna, Louise Harris, Edward Rowland, Angelika Kleinebenne, DENNIS M. KRIKLER, Celia M. Oakley, J. F. Goodwin · 1984 · The American Journal of Cardiology
69. Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population
    Cecchi, F, Olivotto, I, Montereggi, A, Squillatini, G, Dolara, A, Maron, B J · 1998 · Heart
70. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives
    Paal Skytt Andersen, Ole Havndrup, Lotte Hougs, Karina Medin Sorensen, Morten K. Jensen, Lars Allan Larsen, Paula Louise Hedley, Alex Rojas Bie Thomsen, Johanna C. Moolman‐Smook, Michael Christiansen et al. · 2008 · Human Mutation
71. Surgical Myectomy Versus Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
    Iacopo Olivotto, Steve R. Ommen, Martin S. Maron, Franco Cecchi, Barry J. Maron · 2007 · Journal of the American College of Cardiology
72. Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience
    Horst J. Kuhn, Thorsten Lawrenz, Frank Lieder · 2007 · Clinical Research in Cardiology
73. Quality of life and psychological distress in hypertrophic cardiomyopathy mutation carriers: A cross‐sectional cohort study
    Imke Christiaans, Irene M. van Langen, Erwin Birnie, Gouke J. Bonsel, Arthur A.M. Wilde, Ellen M. A. Smets · 2009 · American Journal of Medical Genetics Part A
74. Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy
    Sherif F. Nagueh, Nasser M. Lakkis, Zuo‐Xiang He et al. · 1998 · Journal of the American College of Cardiology
75. DDD pacing in hypertrophic cardiomyopathy: a multicentre clinical experience.
    Alistair Slade, Nicolas Sadoul, Leonard M. Shapiro, Lidia Chojnowska, Jean-Philippe Simon, Richard C. Saumarez, Bernard Dodinot, A. John Camm, William John McKenna, Etienne Aliot · 1996 · Heart
76. Pitfalls in Clinical Recognition and a Novel Operative Approach for Hypertrophic Cardiomyopathy With Severe Outflow Obstruction Due to Anomalous Papillary Muscle
    Barry J. Maron, Rick A. Nishimura, Gordon K. Danielson · 1998 · Circulation
77. Dynamic Left Ventricular Outflow Tract Obstruction in Acute Coronary Syndromes: An Important Cause of New Systolic Murmur and Cardiogenic Shock
    John H. Haley, Lawrence J. Sinak, Abdul Jamil Tajik · 1999 · Mayo Clinic Proceedings
78. Outcome of Mildly Symptomatic or Asymptomatic Obstructive Hypertrophic Cardiomyopathy
    Paul Sorajja, Rick A. Nishimura, Bernard John Gersh, Joseph A. Dearani, David O. Hodge, Heather J. Wiste, Steve R. Ommen · 2009 · Journal of the American College of Cardiology
79. Survival After Cardiac Transplantation in Patients With Hypertrophic Cardiomyopathy
    Martin S. Maron, Benjamin M. Kalsmith, James E. Udelson, Wenjun Li, David D. DeNofrio · 2010 · Circulation Heart Failure
80. Mutation profile of theGAA gene in 40 Italian patients with late onset glycogen storage disease type II
    Anna Lisa E. Montalvo, Bruno Bembi, Mariarosaria Donnarumma, Mirella Filocamo, Giancarlo Parenti, Massimiliano Rossi, Luciano Merlini, Emanuele Buratti, Paola De Filippi, Andrea Dardis et al. · 2006 · Human Mutation
81. Results of surgery for hypertrophic obstructive cardiomyopathy.
    William G. Williams, E.Douglas Wigle, Harry Rakowski, Jeffrey F. Smallhorn, Jacques Gerard LeBlanc, George A. Trusler · 1987 · PubMed
82. Regional left ventricular asynchrony and impaired global left ventricular filling in hypertrophic cardiomyopathy: Effect of verapamil
    Robert O. Bonow, Dino Franco Vitale, Barry J. Maron · 1987 · Journal of the American College of Cardiology
83. Echocardiography in Hypertrophic Cardiomyopathy
    Luis Afonso, Juan Bernal, Jeroen Joost Bax, Theodore P. Abraham · 2008 · JACC. Cardiovascular imaging
84. Long-term propranolol therapy in muscular subaortic stenosis.
    Allan G. Adelman, Pravin M. Shah, Raymond Gramiak, E.Douglas Wigle · 1970 · Heart
85. Longevity of Sprint Fidelis Implantable Cardioverter-Defibrillator Leads and Risk Factors for Failure
    Robert G. Hauser, William H. Maisel, Paul A. Friedman, Linda M. Kallinen, Andrew S. Mugglin, Kapil Kumar, David O. Hodge, Thomas B. Morrison, David L. Hayes · 2011 · Circulation
86. Research Priorities in Hypertrophic Cardiomyopathy
    Thomas L. Force, Robert O. Bonow, Steven R. Houser, Ross John Solaro, Ray E. Hershberger, Bishow B. Adhikari, Mark E. Anderson, Robin Boineau, Barry J. Byrne, Thomas P. Cappola et al. · 2010 · Circulation
87. SCREENING FOR HYPERTROPHIC CARDIOMYOPATHY IN YOUNG ATHLETES
    C Ristina B Asso, M Aurizio S Chiavon, T Hiene · 2009
88. Systolic anterior motion of the posterior mitral leaflet: a previously unrecognized cause of dynamic subaortic obstruction in patients with hypertrophic cardiomyopathy.
    Barry J. Maron, A M Harding, Paolo Spirito, William Clifford Roberts, Bruce F. Waller · 1983 · Circulation
89. Mitral regurgitation in muscular subaortic stenosis
    E.Douglas Wigle, Allan G. Adelman, Pierre Auger · 1969 · The American Journal of Cardiology
90. Effects of verapamil on left ventricular systolic and diastolic function in patients with hypertrophic cardiomyopathy: pressure-volume analysis with a nonimaging scintillation probe.
    Robert O. Bonow, Harold G. Ostrow, Douglas R. Rosing · 1983 · Circulation
91. Studies on Digitalis
    Edmund H. Sonnenblick, John F. Williams, Gerald Glick · 1966 · Circulation
92. Update on Age at Menarche in Italy: Toward the Leveling Off of the Secular Trend
    Franco Rigon, Luigi Bianchin, Sergio Bernasconi, Gianni Bona, Mauro Bozzola, Fabio Buzi, Alessandro Cicognani, Carlo De Sanctis, Vincenzo De Sanctis, Giorgio Radetti et al. · 2009 · Journal of Adolescent Health
93. Spontaneous Variability of Left Ventricular Outflow Tract Gradient in Hypertrophic Obstructive Cardiomyopathy
    Ali M. Kizilbash, Sheila Kim Heinle, Paul Arthur Grayburn · 1998 · Circulation
94. Molecular Genetic Basis of Hypertrophic Cardiomyopathy:
    Ali J. Marian, Robert Roberts · 1998 · Journal of Cardiovascular Electrophysiology
95. Role of Family History of Sudden Death in Risk Stratification and Prevention of Sudden Death With Implantable Defibrillators in Hypertrophic Cardiomyopathy
    Johan Martijn Bos, Barry J. Maron, Michael John Ackerman, Tammy S. Haas, Paul Sorajja, Rick A. Nishimura, Bernard John Gersh, Steve R. Ommen · 2010 · The American Journal of Cardiology
96. A double-blind, placebo-controlled crossover trial of nadolol and verapamil in mild and moderately symptomatic hypertrophic cardiomyopathy
    David M. Gilligan, Wan‐Leong Chan, Jo Joshi, Peter Clarke, ASTRID E. FLETCHER, Shirley J Krikler, Celia M. Oakley · 1993 · Journal of the American College of Cardiology
97. Mid-ventricular obstruction: A variant of obstructive cardiomyopathy
    Raul E. Falicov, Leon Resnekov, Saroja Bharati · 1976 · The American Journal of Cardiology
98. Relation of electrocardiographic abnormalities to evolving left ventricular hypertrophy in hypertrophic cardiomyopathy during childhood
    Julio A. Panza, Barry J. Maron · 1989 · The American Journal of Cardiology
99. ACCF/AHA 2009 Performance Measures for Primary Prevention of Cardiovascular Disease in Adults
    Rita F. Redberg, Emelia J. Benjamin, Vera Bittner, Lynne T. Braun, David Calvin Goff, Stephen Havas, Darwin R. Labarthe, Marian C. Limacher, Donald M. Lloyd‐Jones, Samia Mora et al. · 2009 · Journal of the American College of Cardiology
100. Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy
     BUNCH, T. JARED, MUNGER, THOMAS M, FRIEDMAN, PAUL A, ASIRVATHAM, SAMUEL J, BRADY, PETER A, CHA, YONG‐MEI, REA, ROBERT F, SHEN, WIN‐KUANG, POWELL, BRIAN D, OMMEN, STEVE R et al. · 2008 · Journal of Cardiovascular Electrophysiology
101. Studies on Digitalis
     Eugene Braunwald M. D, Edwin C. Brockenbrough, Robert L. Frye · 1962 · Circulation
102. Myocardial bridging does not predict sudden death in children with hypertrophic cardiomyopathy but is associated with more severe cardiac disease
     SAIDI A. MOHIDDIN, David Begley, Joanna H. Shih · 2000 · Journal of the American College of Cardiology
103. Psychosocial impact of specialized cardiac genetic clinics for hypertrophic cardiomyopathy
     Jodie Ingles, Joanne M. Lind, Philayrath Phongsavan, Christopher Semsarian · 2008 · Genetics in Medicine
104. Management of Symptomatic Hypertrophic Obstructive Cardiomyopathy - Long-Term Results after Surgical Therapy
     Hagen Dietrich Schulte, Konstantin V. Borisov, E. Gams · 1999 · The Thoracic and Cardiovascular Surgeon
105. Follow-Up of Alcohol Septal Ablation for Symptomatic Hypertrophic Obstructive Cardiomyopathy
     Valerian L.C. Fernandes, Christopher D. Nielsen, Sherif F. Nagueh · 2008 · JACC: Cardiovascular Interventions
106. Hypertrophic subaortic stenosis
     Robert E. Stenson, M.D. Flamm, Donald C. Harrison, E. William Hancock · 1973 · The American Journal of Cardiology
107. Comparison of the effects of nitroprusside and nifedipine on diastolic properties in patients with hypertrophic cardiomyopathy: Altered left ventricular loading or improved muscle inactivation?
     Walter J. Paulus, Beverly H. Lorell, William E. Craig · 1983 · Journal of the American College of Cardiology
108. Benefits of intraoperative echocardiography in the surgical management of hypertrophic cardiomyopathy
     Thomas Hugh Marwick, William J. Stewart, Harry M. Lever · 1992 · Journal of the American College of Cardiology
109. Oral disopyramide therapy for obstructive hypertrophic cardiomyopathy
     Mark V. Sherrid, Ernest Delia, Edward Dwyer · 1988 · The American Journal of Cardiology
110. Conduction system abnormalities in patients with obstructive hypertrophic cardiomyopathy following septal reduction interventions
     Jian Xin Qin, Takahiro Shiota, Harry M. Lever et al. · 2004 · The American Journal of Cardiology
111. Clinical Challenges of Genotype Positive (+)–Phenotype Negative (−) Family Members in Hypertrophic Cardiomyopathy
     Barry J. Maron, Laura Yeates, Christopher Semsarian · 2010 · The American Journal of Cardiology
112. Lessons From the Failure and Recall of an Implantable Cardioverter-Defibrillator
     Robert G. Hauser, Barry J. Maron · 2005 · Circulation
113. Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy11There are no financial affiliations to disclose with respect to this article.
     Steve R. Ommen, Rick A. Nishimura, Ray W. Squires · 1999 · Journal of the American College of Cardiology
114. Efficacy of catheter ablation of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy
     Fethi Kılıçaslan, Atul Verma, Eduardo Saad, Sakis Themistoclakis, Aldo Bonso, Antonio Raviele, Hüseyin Bozbaş, Michelle Williams Andrews, Salwa Beheiry, Steven C. Hao et al. · 2006 · Heart Rhythm
115. Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverter-defibrillator
     Paul Dorian, François Philippon, Bernard Thibault, Shane Kimber, Larry D. Sterns, Mary Greene, David M. Newman, Robert Gelaznikas, Aiala Barr · 2004 · Heart Rhythm
116. Ventricular Arrhythmia Following Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
     Peter A. Noseworthy, Michael A. Rosenberg, Michael A. Fifer, Igor F. Palacios, Patricia A. Lowry, Jeremy Neil Ruskin, Danita M. Yoerger Sanborn, Michael H. Picard, Gus J. Vlahakes, Theofanie Mela et al. · 2009 · The American Journal of Cardiology
117. Effect of surgical reduction of left ventricular outflow obstruction on hemodynamics, coronary flow, and myocardial metabolism in hypertrophic cardiomyopathy.
     Richard O. Cannon, Charles L. McIntosh, William H. Schenke, Barry J. Maron, Robert O. Bonow, Stephen E. Epstein · 1989 · Circulation
118. Mutations of the β myosin heavy chain gene in hypertrophic cardiomyopathy: critical functional sites determine prognosis
     Anna Woo, Harry Rakowski, J C Liew, M-S Zhao, C-C Liew, T G Parker, M Zeller, E D Wigle, M J Sole · 2003 · Heart
119. Management Implications of Massive Left Ventricular Hypertrophy in Hypertrophic Cardiomyopathy Significantly Underestimated by Echocardiography but Identified by Cardiovascular Magnetic Resonance
     Martin S. Maron, John R. Lesser, Barry J. Maron · 2010 · The American Journal of Cardiology
120. Disopyramide in hypertrophic cardiomyopathy I. Hemodynamic assessment after intravenous administration
     Charles Pollick, Brian P. Kimball, Mark A. Henderson, E.Douglas Wigle · 1988 · The American Journal of Cardiology
121. Hypertrophic obstructive cardiomyopathy in pediatric patients: Results of surgical treatment
     David A. Theodoro, Gordon K. Danielson, ROBERT H. FELDT, Betty Jane Anderson · 1996 · Journal of Thoracic and Cardiovascular Surgery
122. Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers
     Michelle Michels, Osama I.I. Soliman, Judith E. Phefferkorn, Yvonne M. Hoedemaekers, Marcel J.M. Kofflard, Dennis Dooijes, Danielle F. Majoor‐Krakauer, Folkert J. ten Cate · 2009 · European Heart Journal
123. Role of Transcoronary Ablation of Septal Hypertrophy in Patients With Hypertrophic Cardiomyopathy, New York Heart Association Functional Class III or IV, and Outflow Obstruction Only Under Provocable Conditions
     Frank H. Gietzen, C Leuner, LUDGER OBERGASSEL · 2002 · Circulation
124. Dual effect of disopyramide on atrial and atrioventricular conduction and refractory periods.
     John S Birkhead, E. M. Vaughan Williams · 1977 · Heart
125. Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy
     Ramiro Flores‐Ramírez, Nasser M. Lakkis, Katherine J. Middleton · 2001 · Journal of the American College of Cardiology
126. Usefulness and safety of transcatheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy
     Gaita, Fiorenzo, Di Donna, Paolo, Olivotto, Iacopo, Scaglione, Marco, Ferrero, Ivana, Montefusco, Antonio, Caponi, Domenico, Conte, Maria Rosa, Nistri, Stefano, Cecchi, Franco · 2007 · The American Journal of Cardiology
127. Reversible obstruction of the ventricular outflow tract
     Norman Krasnow, Ellis L. Rolett, William B. Hood · 1963 · The American Journal of Cardiology
128. Implantable Cardioverter-Defibrillator Therapy for Primary Prevention of Sudden Death After Alcohol Septal Ablation of Hypertrophic Cardiomyopathy
     Frank A. Cuoco, William H. Spencer, Valerian L.C. Fernandes, Christopher D. Nielsen, Sherif F. Nagueh, John Lacy Sturdivant, Robert B. Leman, John Marcus Wharton, Michael Robert Gold · 2008 · Journal of the American College of Cardiology
129. Alcohol septal ablation for hypertrophic cardiomyopathy: Indications and technique
     David R. Holmes, Uma S. Valeti, Rick A. Nishimura · 2005 · Catheterization and Cardiovascular Interventions
130. Implantable Defibrillators and Prevention of Sudden Death in Hypertrophic Cardiomyopathy
     Barry J. Maron, Paolo Spirito · 2008 · Journal of Cardiovascular Electrophysiology
131. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery
     Jian Xin Qin, T. Shiiota, Harry M. Lever · 2002 · ACC Current Journal Review
132. Left Ventricular Outflow Tract Gradient Variability in Hypertrophic Cardiomyopathy
     Jeffrey Benjamin Geske, Paul Sorajja, Steve R. Ommen, Rick A. Nishimura · 2009 · Clinical Cardiology
133. Diastolic Compliance of Hypertrophied Ventricle Is Not Acutely Altered by Pharmacologic Agents Influencing Active Processes
     David A. Kass, Matthew R. Wolff, Chih-Tai Ting · 1993 · Annals of Internal Medicine
134. Idiopathic Hypertrophic Subaortic Stenosis: III. Intraoperative Studies of the Mechanism of Obstruction and Its Hemodynamic Consequences
     George E. Pierce, Andrew G. Morrow, Eugene Braunwald M. D · 1964 · Circulation
135. Long-term follow-up of patients undergoing myotomy/myectomy for obstructive hypertrophic cardiomyopathy
     Lawrence H. Cohn, Hemant Trehan, John J. Collins · 1992 · The American Journal of Cardiology
136. What Is the Best Surgical Treatment for Obstructive Hypertrophic Cardiomyopathy and Degenerative Mitral Regurgitation?
     Calvin K.N. Wan, Joseph A. Dearani, Thoralf M. Sundt · 2009 · The Annals of Thoracic Surgery
137. Time Course of Pressure Gradient Response After First Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
     Danita M. Yoerger, Michael H. Picard, Igor F. Palacios · 2006 · The American Journal of Cardiology
138. Demonstration of the dynamic nature of idiopathic hypertrophic subaortic stenosis
     Robert E. Whalen, Allan I. Cohen, Robert G. Sumner · 1963 · The American Journal of Cardiology
139. Hemodynamic determinants of exercise-induced abnormal blood pressure response in hypertrophic cardiomyopathy
     Quirino Ciampi, Sandro Betocchi, Raffaella Lombardi, Fiore Manganelli, Giovanni Storto, Maria Angela Losi, Elpidio Pezzella, Filippo Finizio, Alberto Cuocolo, Massimo Chiariello A · 2002 · Journal of the American College of Cardiology
140. Risk Stratification and Role of Implantable Defibrillators for Prevention of Sudden Death in Patients With Hypertrophic Cardiomyopathy
     Barry J. Maron · 2010 · Circulation Journal
141. Long-Term Outcomes in High-Risk Symptomatic Patients With Hypertrophic Cardiomyopathy Undergoing Alcohol Septal Ablation
     Deborah H. Kwon, Samir Ramesh Kapadia, Emin Murat Tuzcu et al. · 2008 · JACC: Cardiovascular Interventions
142. Heart Transplantation in Hypertrophic Cardiomyopathy
     Elena Biagini, Paolo Spirito, Ornella Leone, Fernando Maria Picchio, Fabio Coccolo, Luca Ragni, Carla Lofiego, Francesco Grigioni, Luciano Potena, Guido Rocchi et al. · 2007 · The American Journal of Cardiology
143. Sudden Cardiac Arrest in Hypertrophic Cardiomyopathy in the Absence of Conventional Criteria for High Risk Status
     Barry J. Maron, Martin S. Maron, John R. Lesser, Robert G. Hauser, Tammy S. Haas, Caitlin J. Harrigan, Evan A. Appelbaum, Michael L. Main, William Clifford Roberts · 2007 · The American Journal of Cardiology
144. Effectiveness of atrial fibrillation surgery in patients with hypertrophic cardiomyopathy
     Michael S. Chen, Patrick M. McCarthy, Harry M. Lever, Nicholas Gerard Smedira, Bruce Lytle · 2004 · The American Journal of Cardiology
145. Clinical and hemodynamic results after mitral valve replacement in patients with obstructive hypertrophic cardiomyopathy
     Charles L. McIntosh, Gail J. Greenberg, Barry J. Maron · 1989 · The Annals of Thoracic Surgery
146. A DNA resequencing array for pathogenic mutation detection in hypertrophic cardiomyopathy
     Siv Fokstuen, Robert Lyle, Analia Muñoz et al. · 2008 · Human Mutation
147. Echocardiographic assessment of mitral valve size in obstructive hypertrophic cardiomyopathy. Anatomic validation from mitral valve specimen.
     Heinrich G. Klues, Michael A. Proschan, Allen L. Dollar, Paolo Spirito, William Clifford Roberts, Barry J. Maron · 1993 · Circulation
148. Disopyramide in hypertrophic cardiomyopathy II. Noninvasive assessment after oral administration
     Charles Pollick · 1988 · The American Journal of Cardiology
149. The Electrocardiogram as a Diagnostic Tool for Hypertrophic Cardiomyopathy: Revisited
     Barry J. Maron · 2001 · Annals of Noninvasive Electrocardiology
150. Effect of Biventricular Pacing on Symptoms and Cardiac Remodelling in Patients with End-Stage Hypertrophic Cardiomyopathy
     Dominic P. S. Rogers, Stefania Marazìa, ANTHONY W.C. CHOW · 2008 · European Journal of Heart Failure
151. Percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: Managing the risk of procedure-related AV conduction disturbances
     Lothar Faber, Dirk Welge, Dieter Faßbender · 2006 · International Journal of Cardiology
152. Diastolic Myocardial Mechanics in Hypertrophic Cardiomyopathy
     Shemy Carasso, Hua Yang, Anna Woo · 2010 · Journal of the American Society of Echocardiography
153. Short Communication: The Cardiac Myosin Binding Protein C Arg502Trp Mutation
     Adam J. Saltzman, Debora Mancini‐DiNardo, Chumei C. Li, Wendy K. Chung, Carolyn Yung Ho, Stephanie Hurst, Julia Wynn, Melanie E. Care, Robert Murray Hamilton, Gregor W. Seidman et al. · 2010 · Circulation Research
154. A prospective follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy-The baylor experience (1996-2002)
     Valerian L.C. Fernandes, Sherif F. Nagueh, Jennifer L. Franklin · 2005 · Clinical Cardiology
155. Muscular subaortic stenosis
     E.Douglas Wigle, Paul Robert David, Claude J. Labrosse · 1965 · The American Journal of Cardiology
156. Utility of Isoproterenol to Provoke Outflow Tract Gradients in Patients With Hypertrophic Cardiomyopathy
     Ahmad A. Elesber, Rick A. Nishimura, Charanjit S. Rihal · 2007 · The American Journal of Cardiology
157. Significant improvement of quality of life following atrioventricular synchronous pacing in patients with hypertrophic obstructive cardiomyopathy. Data from 1 year of follow-up
     Fredrik Gadler · 1999 · European Heart Journal
158. Quantifying Diastolic Function in Hypertrophic Cardiomyopathy
     Harry Rakowski, Shemy Carasso · 2007 · Circulation
159. Has 'obstruction' hindered our understanding of hypertrophic cardiomyopathy?
     J. Michael Criley, Robert James Siegel · 1985 · Circulation
160. The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on predictive screening
     Imke Christiaans, Erwin Birnie, Irene M. van Langen, Karin Y. van Spaendonck‐Zwarts, J. Peter van Tintelen, Maarten P. van den Berg, Douwe E. Atsma, A.T.J.M. Helderman-van den Enden, Yigal M. Pinto, J.F. Hermans-van Ast et al. · 2009 · European Heart Journal
161. Non-invasive assessment of diastolic function in hypertrophic cardiomyopathy on and off beta adrenergic blocking drugs.
     Roando F. Alvares, J. F. Goodwin · 1982 · Heart
162. Cardioverter-defibrillator implantation in high-risk patients with hypertrophic cardiomyopathy
     Adrian K. Almquist, Julia V. Montgomery, Tammy S. Haas, Barry J. Maron · 2005 · Heart Rhythm
163. Sustained improvement in left ventricular diastolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy
     Davinder S. Jassal · 2006 · European Heart Journal
164. Left Ventricular Outflow Tract Obstruction as a Risk Factor for Sudden Cardiac Death in Hypertrophic Cardiomyopathy
     Georgios K. Efthimiadis, Despoina G. Parcharidou, George A. Giannakoulas, Efstathios D. Pagourelias, Panagiotis E. Charalampidis, Gregorios Savvopoulos, Antonios Ziakas, Haralambos I. Karvounis, Ioannis Stylıadis, Georgios E. Parcharidis · 2009 · The American Journal of Cardiology
165. Salutary effect of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy
     Hiromi Matsubara, Satoshi Nakatani, Seiki Nagata, Fuminobu Ishikura, Yuichi Katagiri, Tohru Ohe, Kunio Miyatake · 1995 · Journal of the American College of Cardiology
166. A high risk phenotype of hypertrophic cardiomyopathy associated with a compound genotype of two mutated β-myosin heavy chain genes
     Brigitte Jeschke, Kerstin Uhl, Bernd Weist, Dirk Schröder, Thomas Meitinger, C Döhlemann, Hans-Peter Vosberg · 1998 · Human Genetics
167. How should hypertrophic cardiomyopathy be classified?
     Barry J. Maron, Christine E. Seidman, Michael John Ackerman, Jeffrey Allen Towbin, Martin S. Maron, Steve R. Ommen, Rick A. Nishimura, Bernard John Gersh · 2009 · Circulation Cardiovascular Genetics
168. Resection-Plication-Release for Hypertrophic Cardiomyopathy: Clinical and Echocardiographic Follow-Up
     Sandhya K. Balaram, Leslie Steele Tyrie, Mark V. Sherrid, John N. Afthinos, Zak Hillel, Glenda Winson, Daniel G. Swistel · 2008 · The Annals of Thoracic Surgery
169. Left Atrial Appendage Occlusion — Closure or Just the Beginning?
     William H. Maisel · 2009 · New England Journal of Medicine
170. Use of Echocardiography in Patients with Hypertrophic Cardiomyopathy: Clinical Implications of Massive Hypertrophy
     Paul Sorajja, Rick A. Nishimura, Steve R. Ommen, Michael John Ackerman, Abdul Jamil Tajik, Bernard John Gersh · 2006 · Journal of the American Society of Echocardiography
171. Morphologic determinants of hemodynamic state after ventricular septal myotomy-myectomy in patients with obstructive hypertrophic cardiomyopathy: M mode and two-dimensional echocardiographic assessment.
     Paolo Spirito, Barry J. Maron, Douglas R. Rosing · 1984 · Circulation
172. Ventricular Tachycardia Complicating Alcohol Septal Ablation
     Chester M. Boltwood, Walter W. Chien, Thomas A. Ports · 2004 · New England Journal of Medicine
173. Relation of left ventricular thickness to age and gender in hypertrophic cardiomyopathy
     Barry J. Maron, Susan A. Casey, David G. Hurrell, Dorothee M. Aeppli · 2003 · The American Journal of Cardiology
174. Impact of surgical relief of outflow obstruction on thallium perfusion abnormalities in hypertrophic cardiomyopathy.
     Richard O. Cannon, Vasken Dilsizian, Patrick T. O’Gara · 1992 · Circulation
175. Effect of Sotalol on Arrhythmias and Exercise Tolerance in Patients with Hypertrophic Cardiomyopathy
     Michał Tendera, Anna Wycisk, Adam Schneeweiss · 2008 · Cardiology
176. Transcoronary Ablation of Septal Hypertrophy Does Not Alter ICD Intervention Rates in High Risk Patients with Hypertrophic Obstructive Cardiomyopathy
     Thorsten Lawrenz, LUDGER OBERGASSEL, Frank Lieder · 2005 · Pacing and Clinical Electrophysiology
177. Determinants for Clinical Diagnosis of Hypertrophic Cardiomyopathy
     Selçuk Adabağ, Michael A. Kuskowski, Barry J. Maron · 2006 · The American Journal of Cardiology
178. Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: past, present and future
     Steve R. Ommen, Pravin M. Shah, Abdul Jamil Tajik · 2008 · Heart
179. Delayed Untwisting
     Jianwen Wang, John M. Buergler, Kumuthavally Veerasamy · 2009 · Journal of the American College of Cardiology
180. Mitral regurgitation due to ruptured chordae tendineae in patients with hypertrophic obstructive cardiomyopathy
     Wei-Xi Zhu, Jae K. Oh, Stephen Louis Kopecky · 1992 · Journal of the American College of Cardiology
181. Pathological effects of alcohol septal ablation for hypertrophic obstructive cardiomyopathy
     Aaron Leigh Baggish, Rex Neal Smith, Igor F. Palacios · 2006 · Heart
182. Acute Predictors of Subacute Complete Heart Block After Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
     Annabel Chen‐Tournoux, Igor F. Palacios, Theofanie Mela · 2005 · The American Journal of Cardiology
183. Influence of right ventricular pacing site on left ventricular outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy
     Fredrik Gadler, Cecilia Marianne Linde, Anders Juhlin-Dannfeldt · 1996 · Journal of the American College of Cardiology
184. Genetic counseling and cardiac care in predictively tested hypertrophic cardiomyopathy mutation carriers: The patients' perspective
     Imke Christiaans, Irene M. van Langen, Erwin Birnie, Gouke J. Bonsel, Arthur A.M. Wilde, Ellen M. A. Smets · 2009 · American Journal of Medical Genetics Part A
185. Improvement in exercise capacity and exercise blood pressure response after transcoronary alcohol ablation therapy of septal hypertrophy in hypertrophic cardiomyopathy
     Jae‐Joong Kim, Cheol Whan Lee, Seong-Wook Park · 1999 · The American Journal of Cardiology
186. Effect of propranolol on left ventricular relaxation in hypertrophic cardiomyopathy: An echographic study
     Claude Bourmayan, Amir Razavi, Claude Fournier · 1985 · American Heart Journal
187. Ventricular fibrillation in MYH7-related hypertrophic cardiomyopathy before onset of ventricular hypertrophy
     Imke Christiaans, Ronald H. Lekanne Deprez, Irene M. van Langen · 2009 · Heart Rhythm
188. Circadian patterns in the occurrence of malignant ventricular tachyarrhythmias triggering defibrillator interventions in patients with hypertrophic cardiomyopathy
     Barry J. Maron, Christopher Semsarian, Win-Kuang Shen, Mark S. Link, Andrew E. Epstein, N.A. Mark Estes, Adrian K. Almquist, MICHAEL C. GIUDICI, Tammy S. Haas, James S. Hodges et al. · 2009 · Heart Rhythm
189. Long-term survival after cardiac arrest in hypertrophic cardiomyopathy
     Barry J. Maron, Tammy S. Haas, Kevin M. Shannon, Adrian K. Almquist, James S. Hodges · 2009 · Heart Rhythm
190. Changes in the left ventricular outflow tract after transcoronary ablation of septal hypertrophy (TASH) for hypertrophic obstructive cardiomyopathy as assessed by transoesophageal echocardiography and by measuring myocardial glucose utilization and perfusion
     Horst J. Kuhn · 1999 · European Heart Journal
191. Outcomes of Pediatric Patients With Hypertrophic Cardiomyopathy Listed for Transplant
     Robert J. Gajarski, David C. Naftel, Elfriede Pahl · 2009 · The Journal of Heart and Lung Transplantation
192. Transcoronary ablation of septal hypertrophy for hypertrophic obstructive cardiomyopathy: feasibility, clinical benefit, and short term results in elderly patients
     Frank H. Gietzen, C J Leuner, L Obergassel · 2004 · Heart
193. Drugs Five Years Later: Disopyramide
     Fred Morady, MELVIN M. SCHEINMAN, JAWAHAR DESAI · 1982 · Annals of Internal Medicine
194. Results of permanent dual-chamber pacing in symptomatic nonobstructive hypertrophic cardiomyopathy
     Richard O. Cannon, Dorothy J. Tripodi, Vasken Dilsizian · 1994 · The American Journal of Cardiology
195. Effects of Diltiazem on Left Ventricular Systolic and Diastolic Function in Hypertrophic Cardiomyopathy**This study was supported in part by Grant 18/1/57 1994–1995 from the Italian Ministry of University and Scientific Research (MURST 60%), Rome, Italy.
     Sandro Betocchi, Federico Piscione, Maria Angela Losi et al. · 1996 · The American Journal of Cardiology
196. Results of operation for hypertrophic obstructive cardiomyopathy in children and adults less than 40 years of age.
     Rephael Mohr, Hartzell Vernon Schaff, Francisco J. Puga · 1989 · PubMed
197. Current status of alcohol septal ablation for patients with hypertrophic cardiomyopathy
     Hubert Seggewiß · 2001 · Current Cardiology Reports
198. Extreme tachycardia complicating the use of disopyramide in atrial flutter.
     C E Robertson, H C Miller · 1980 · Heart
199. Hypertrophic cardiomyopathy: current understanding and treatment objectives
     Gursharan S. Soor, Andrea O. Y. Luk, Eric Ahn, J R Abraham, Anna Woo, Anthony C. Ralph-Edwards, JAGDISH W. BUTANY · 2008 · Journal of Clinical Pathology
200. Prevention of Sudden Death in Hypertrophic Cardiomyopathy
     Giuseppe Boriani, Barry J. Maron, Win-Kuang Shen, Paolo Spirito · 2004 · Circulation